Fentanyl Pediatric Dose — Analgesia
Fentanyl is a potent synthetic opioid analgesic that exerts its effect through agonism at mu-opioid receptors, producing dose-dependent analgesia and sedation. It is widely used in pediatric settings for the management of moderate-to-severe acute pain, procedural analgesia, and analgesia in critically ill patients. Its rapid onset and relatively short duration of action make it particularly useful in emergency and intensive care environments.
Pediatric Dosing
The recommended intermittent IV dose for pediatric analgesia is 1–2 mcg/kg per dose, administered intravenously every 1 hour as needed (PRN).
- Dose: 1–2 mcg/kg IV per dose
- Frequency: Every 1 hour PRN
- Route: Intravenous (IV)
Worked example: For a 20 kg child: 20 × 1 mcg/kg = 20 mcg (low end) to 20 × 2 mcg/kg = 40 mcg (high end) per dose. Consult institutional protocol for maximum single-dose limits and cumulative dosing guidance.
Indications and Clinical Context
Fentanyl at this intermittent dosing regimen is indicated for the management of moderate-to-severe acute pain in pediatric patients requiring IV opioid analgesia. Common clinical contexts include post-operative pain management, pain associated with acute illness or trauma, and analgesia in PICU or emergency department settings. Its favorable pharmacokinetic profile—rapid onset within 1–2 minutes and peak effect at approximately 3–5 minutes—supports titratable, goal-directed pain management.
Opioid analgesics such as fentanyl are a cornerstone of multimodal pain strategies in pediatric acute care. Dosing should be individualized based on pain severity, patient age, weight, and clinical status, with reassessment at each PRN interval to determine ongoing need.
Administration and Monitoring
Administer each dose as a slow IV push over 1–2 minutes to reduce the risk of chest wall rigidity, which can occur with rapid infusion, particularly at higher doses. Ensure that resuscitation equipment and reversal agent (naloxone) are immediately available prior to administration. Monitor respiratory rate, oxygen saturation, sedation level, and hemodynamic parameters closely following each dose.
- Route: Intravenous (IV) as specified; consult institutional protocol for alternative routes
- Adverse effects to monitor: Respiratory depression, hypoxia, hypotension, bradycardia, chest wall rigidity, nausea, and pruritus
- Contraindications/cautions: Use with caution in patients with respiratory compromise, hemodynamic instability, or concomitant CNS depressant use
- Reversal: Naloxone should be available at the bedside for opioid-induced respiratory depression
- Max dose: Not specified in source — consult institutional protocol
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.